Empowering global drug discovery and development : Medicilon's International Discovery Service Unit(IDSU)

Introduction of International Discovery Service Unit(IDSU)

In 2021, Medicilon established the International Discovery Service Unit (IDSU) to provide global pharmaceutical companies with high quality, high efficient and cost-effective chemistry synthesis design and production, medicinal chemistry, and the discovery and project delivery of clinical candidate compounds, which empowering global drug research and development.

Team & Equipment Introduction

Medicilon’s IDSU has united an all-round team, with more than 100 synthetic chemistry and medicinal chemists, as well as a management team and experimental personnel with rich overseas study background.  In addition, Medicilon equipped with world-advanced synthetic laboratories, analytical laboratories, and state-of-the-art instruments and equipment, such as ASAP MASS, glove box, peptide synthesizer, various photochemical reactors, and electrochemical reactors, which provide strong support for drug research and development.

Advanced Technology

In the past two years, the Medicilon’ IDSU has been constantly empowering and accumulating momentum, striving to promote the leap from quantitative accumulation to qualitative, and to be at the forefront of new technologies in global drug design and synthesis.  Medicilon actively develops and introduces artificial intelligence/machine learning (AI/ML), protein degradation targeting chimera (PROTAC), highly active drugs and antibody drug conjugates (ADC), direct functionalization of inert carbon-hydrogen bonds, photoredox reactions, as well as the development of new technologies such as flow chemistry, leading the new trend of global drug discovery.

Related Services about "International Drug Discovery and Development"